ConductScience.org, home

Gene · 3190

HNRNPK: heterogeneous nuclear ribonucleoprotein K

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. HNRNPK: heterogeneous nuclear ribonucleoprotein K. Genes, record 3190. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3190

On this page

Gene

Symbol
HNRNPK
HGNC
Name
heterogeneous nuclear ribonucleoprotein K
HGNC
NCBI Gene ID
3190
NCBI Gene
HGNC ID
HGNC:5044
HGNC
Ensembl
ENSG00000165119
NCBI Gene
Aliases
AUKS, CSBP, HNRPK, TUNP
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P61978Heterogeneous nuclear ribonucleoprotein K4639Ensembl, GeneID, HGNC

Source UniProt

Patents82

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-195135P61978Espacenet
EP 4641201 A22025-10-294732P61978Espacenet
JP 2025147176 A2025-10-0615109P61978Espacenet
JP 2025517969 A2025-06-124732P61978Espacenet
JP 2025517970 A2025-06-125135P61978Espacenet
JP 2025028160 A2025-02-2815109P61978Espacenet
KR 1020250010750 A2025-01-2115109P61978Espacenet
JP 2024109657 A2024-08-1414948P61978Espacenet
US 11446398 B22022-09-2038089P61978Espacenet
US 11446398 B22022-09-2038090P61978Espacenet

1 to 10 of 82

See all 82 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,150

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHNRNPK papersNewest fiscal year
P30CA016672Cancer Center Support Grant182025
P30CA016058Cancer Center Support Grant132025
P30CA008748Cancer Center Support Grant112025
ZIAAG000511Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis112025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging92025
ZIASC010357Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses92025
T32CA009110Training in Areas Fundamental to Cancer Research82025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant62025
R01AI125524Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection62025
P30CA014051Cancer Center Support (Core) Grant52025

1 to 10 of 2,150Source NIH's project files

See all 2,150 nih grants

Papers3,914

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
SHANK3 regulates nuclear hnRNP K and oxidative stress-associated DNA damage signaling in neurons.Neurobiol Dis202642815651PubTator, text miningPubMed
Identification of a necroptosis-related lncRNA prognostic signature and the hub RBP HNRNPK in esophageal squamous cell carcinoma.J Int Med Res202642754824PubTator, text miningPubMed
CircExor enables interpretable prediction of circRNA localization into extracellular vesicles.Genome Res202642754397PubTator, text miningPubMed
An Increased Circular RNA, circRNPS1, in T Cells of Ankylosing Spondylitis Patients Enhances the MEK/ERK Signaling and Inflammation Mediated by T Cell Activation via Stabilization of hnRNPK and VAV1.Int J Mol Sci202642737453PubTator, text miningPubMed
Beyond in silico prediction: multi-omics to identify a pathogenic deep intronic HNRNPK variant in Au-Kline syndrome.J Hum Genet202642697962PubTator, text miningPubMed
Case Report: A novel HNRNPK gene variant causing Au-Kline syndrome; the genotype and phenotype of the oldest individual ever described.Front Psychiatry202642630720PubTator, text miningPubMed
Machine Learning-Based Screening of Optimal miRNA Targets Enabled by a Cytosolic Delivery Carrier for Augmenting Cancer Therapy.Adv Mater202642615487PubTator, text miningPubMed
hnRNP A1 controls MIR17HG alternative splicing and maturation of miR-19a.Mol Biol Rep202642584802PubTator, text miningPubMed
SnoRNA and SNHG in Bladder Cancer: Molecular Mechanisms and Clinical Significance.Curr Issues Mol Biol202642510903PubTator, text miningPubMed
PCK2 Promotes Ribosome Biogenesis in Cervical Cancer Cells via Interaction with hnRNPK.Reprod Sci202642443589PubTator, text miningPubMed

1 to 10 of 3,914

See all 3,914 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3190

GET https://conductscience.org/api/genes/v1/3190/patents?page=2